Influence of Early and Late Zoledronic Acid Administration on Vertebral Structure and Strength in Ovariectomized Rats

被引:16
作者
Brouwers, Julienne E. M. [1 ,2 ,3 ]
van Rietbergen, Bert [3 ]
Bouxsein, Mary L. [1 ,2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
[3] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands
关键词
Bisphosphonate; Bone architecture/structure; Osteoporosis; Animal model;
D O I
10.1007/s00223-008-9160-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An annual infusion of zoledronic acid (ZOL) reduces fracture riskin osteoporotic patients. Previously, we showed that a single ZOL injection inhibited changes in bone microstructure and strength in rat tibiae after ovariectomy. Here, we determined the effects of a single ZOL injection as preventive and restorative treatment on the bone micro-structure and strength in lumbar and caudal vertebrae of ovariectomized (OVX) rats. Twenty-nine female 35-week-old Wistar rats were divided into four groups: SHAM-OVX (n = 9), OVX (n = 7). ZOL was given once (20 mu g/kg body weight s.c.) at OVX. Trabecular and cortical bone microarchitecture were measured in lumbar (L3) and caudal (Cd6) vertebrae using micro-computed tomography, and compressive mechanical properties were determined in L3 vertebrae. Compared to SHAM-OVX, OVX rats had significantly lower BV/TV; SMI, Tb.N, Tb.Sp, and Conn.D tended to be deteriorated in lumbar vertebrae, while both ZOL groups did not differ from the SHAM-OVX group. Both ZOL groups had significantly higher BV/TV than OVX; the early ZOL group also had significantly lower SMI and higher Tb.Th. OVX tended to decrease mechanical properties, while early and late ZOL treatment inhibited OVX-inducible degeneration. Neither OVX nor ZOL induced changes in the trabecular microarchitecture of caudal vertebrae. In summary, in adult rats a single ZOL injection inhibited OVX-induced changes in lumbar vertebral bone microarchitecture and strength.
引用
收藏
页码:186 / 191
页数:6
相关论文
共 21 条
[1]   Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].
Black, Dennis M. ;
Delmas, Pierre D. ;
Eastell, Richard ;
Reid, Ian R. ;
Boonen, Steven ;
Cauley, Jane A. ;
Cosman, Felicia ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Mautalen, Carlos ;
Mesenbrink, Peter ;
Hu, Huilin ;
Caminis, John ;
Tong, Karen ;
Rosario-Jansen, Theresa ;
Krasnow, Joel ;
Hue, Trisha F. ;
Sellmeyer, Deborah ;
Eriksen, Erik Fink ;
Cummings, Steven R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822
[2]   Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography [J].
Borah, B ;
Dufresne, TE ;
Chmielewski, PA ;
Johnson, TD ;
Chines, A ;
Manhart, MD .
BONE, 2004, 34 (04) :736-746
[3]   Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography [J].
Brouwers, J. E. M. ;
Lambers, F. M. ;
Gasser, J. A. ;
van Rietbergen, B. ;
Huiskes, R. .
CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (03) :202-211
[4]   No effects of in vivo micro-CT radiation on structural parameters and bone marrow cells in proximal tibia of Wistar rats detected after eight weekly scans [J].
Brouwers, Julienne E. M. ;
Van Rietbergen, Bert ;
Huiskes, Rik .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2007, 25 (10) :1325-1332
[5]   A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats [J].
Gasser, Juerg A. ;
Green, Jonathan R. ;
Shen, Victor ;
Ingold, Peter ;
Rebmann, Andrea ;
Bhatnagar, Ajay S. ;
Evans, Dean B. .
BONE, 2006, 39 (04) :787-795
[6]   Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat [J].
Gasser, Jurg A. ;
Ingold, Peter ;
Venturiere, Andrea ;
Shen, Victor ;
Green, Jonathan R. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (04) :544-551
[7]   The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them [J].
Gasser, Jurg A. .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (03) :313-318
[8]   Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid [J].
Glatt, M ;
Pataki, A ;
Evans, GP ;
Hornby, SB ;
Green, JR .
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (09) :707-715
[9]  
Glatt M., 2001, European Cells & Materials, V1, P18
[10]   Preservation of thoracic spine microarchitecture by alendronate: Comparison of histology and microCT [J].
Hordon, LD ;
Itoda, M ;
Shore, PA ;
Shore, RC ;
Heald, M ;
Brown, M ;
Kanis, JA ;
Rodan, GA ;
Aaron, JE .
BONE, 2006, 38 (03) :444-449